Application | Comment | Organism |
---|---|---|
drug development | mutually exclusive substrate specificities and substantial differences between the active sites of the Leishmania major and human GLO1 enzymes indicate that selective inhibition of LmGLO1 may be possible | Leishmania major |
Cloned (Comment) | Organism |
---|---|
- |
Leishmania major |
- |
Homo sapiens |
Crystallization (Comment) | Organism |
---|---|
to 2.0 A resolution, three protein dimers per asymmetric unit in spacegroup P21212, structural differences from both Escherichia coli GLO1 and human GLO1, loop between strands beta6 and beta7 is shortened, 15-residue C-terminal helix is not present in Escherichia coli GLO1, although a helix is observed at the C-terminus of human GLO1, it is in a different orientation and 10 residues shorter | Leishmania major |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
S-2,4-dinitrophenylglutathione | - |
Homo sapiens | |
S-2,4-dinitrophenylglutathione | - |
Leishmania major | |
S-2,4-dinitrophenylglutathionylspermidine | - |
Homo sapiens | |
S-2,4-dinitrophenylglutathionylspermidine | - |
Leishmania major | |
S-4-bromobenzylglutathione | - |
Homo sapiens | |
S-4-bromobenzylglutathione | - |
Leishmania major | |
S-4-bromobenzylglutathionylspermidine | linear competitive inhibitor | Homo sapiens | |
S-4-bromobenzylglutathionylspermidine | linear competitive inhibitor | Leishmania major |
KM Value [mM] | KM Value Maximum [mM] | Substrate | Comment | Organism | Structure |
---|---|---|---|---|---|
0.042 | - |
glutathione ethyl ester | - |
Homo sapiens | |
0.049 | - |
glutathione | - |
Homo sapiens | |
0.053 | - |
glutathione isopropyl ester | - |
Homo sapiens | |
0.064 | - |
N-[3-[(4-aminobutyl)amino]propyl]-L-gamma-glutamyl-L-cysteinylglycine | - |
Leishmania major | |
0.071 | - |
trypanothione | - |
Leishmania major | |
0.13 | - |
trypanothione | - |
Homo sapiens | |
0.148 | - |
N-[3-[(4-aminobutyl)amino]propyl]-L-gamma-glutamyl-L-cysteinylglycine | - |
Homo sapiens | |
0.3 | - |
glutathione isopropyl ester | - |
Leishmania major | |
0.7 | - |
glutathione ethyl ester | - |
Leishmania major | |
1.9 | - |
glutathione | - |
Leishmania major |
Metals/Ions | Comment | Organism | Structure |
---|---|---|---|
Ni2+ | - |
Leishmania major | |
Zn2+ | - |
Homo sapiens |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | Q04760 | - |
- |
Leishmania major | Q68RJ8 | - |
- |
Purification (Comment) | Organism |
---|---|
- |
Leishmania major |
- |
Homo sapiens |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
glutathione + methylglyoxal | - |
Homo sapiens | S-D-lactoylglutathione | - |
? | |
glutathione + methylglyoxal | very poor substrate, specificity constant 280fold lower than of the N1-glutathionylspermidine | Leishmania major | S-D-lactoylglutathione | - |
? | |
glutathione ethyl ester + methylglyoxal | - |
Homo sapiens | ? | - |
? | |
glutathione ethyl ester + methylglyoxal | - |
Leishmania major | S-lactoylglutathionyl ethyl ester | - |
? | |
glutathione ethyl ester + methylglyoxal | - |
Homo sapiens | S-lactoylglutathionyl ethyl ester | - |
? | |
glutathione isopropyl ester + methylglyoxal | - |
Leishmania major | S-lactoylglutathionyl isopropyl ester | - |
? | |
glutathione isopropyl ester + methylglyoxal | - |
Homo sapiens | S-lactoylglutathionyl isopropyl ester | - |
? | |
N1-glutathionylspermidine + methylglyoxal | - |
Leishmania major | ? | - |
? | |
N1-glutathionylspermidine + methylglyoxal | specificity constant of N1-glutathionylspermidine 50fold less than of glutathione | Homo sapiens | ? | - |
? | |
trypanothione + methylglyoxal | - |
Leishmania major | S,S'-bis((R)-lactoyl)trypanothione | - |
? | |
trypanothione + methylglyoxal | - |
Homo sapiens | S,S'-bis((R)-lactoyl)trypanothione | - |
? |
Synonyms | Comment | Organism |
---|---|---|
Glo1 | - |
Leishmania major |
Glo1 | - |
Homo sapiens |
glyoxalase I | - |
Leishmania major |
glyoxalase I | - |
Homo sapiens |
Turnover Number Minimum [1/s] | Turnover Number Maximum [1/s] | Substrate | Comment | Organism | Structure |
---|---|---|---|---|---|
83 | - |
N-[3-[(4-aminobutyl)amino]propyl]-L-gamma-glutamyl-L-cysteinylglycine | - |
Homo sapiens | |
104 | - |
trypanothione | - |
Homo sapiens | |
164 | - |
glutathione ethyl ester | - |
Homo sapiens | |
222 | - |
glutathione isopropyl ester | - |
Homo sapiens | |
1070 | - |
trypanothione | - |
Leishmania major | |
1170 | - |
glutathione isopropyl ester | - |
Leishmania major | |
1360 | - |
glutathione | - |
Homo sapiens | |
1590 | - |
N-[3-[(4-aminobutyl)amino]propyl]-L-gamma-glutamyl-L-cysteinylglycine | - |
Leishmania major |
Ki Value [mM] | Ki Value maximum [mM] | Inhibitor | Comment | Organism | Structure |
---|---|---|---|---|---|
0.000128 | - |
S-4-bromobenzylglutathione | - |
Homo sapiens | |
0.000536 | - |
S-4-bromobenzylglutathionylspermidine | - |
Leishmania major | |
0.0126 | - |
S-4-bromobenzylglutathionylspermidine | - |
Homo sapiens | |
0.5 | - |
S-2,4-dinitrophenylglutathione | - |
Leishmania major | |
0.5 | - |
S-4-bromobenzylglutathione | - |
Leishmania major | |
0.645 | - |
S-2,4-dinitrophenylglutathione | - |
Homo sapiens | |
0.669 | - |
S-2,4-dinitrophenylglutathionylspermidine | - |
Leishmania major | |
0.915 | - |
S-2,4-dinitrophenylglutathionylspermidine | - |
Homo sapiens |